|
KMID : 0370220220660060310
|
|
Yakhak Hoeji
2022 Volume.66 No. 6 p.310 ~ p.315
|
|
|
Impact of Collaboration on Clinical Development Time
|
|
Park Yeong-Hun
Lee Sang-Won
|
|
|
Abstract
|
|
|
|
This research investigated how collaborations affect drug development, including innovation speed andproductivity in the field of new drug development. Two-hundred and twenty new drugs approved by the Food and DrugAdministration (FDA) between 2015 and 2019 were analyzed for the duration of each clinical phase using theClinicaltrials.gov database. Collaborative drug development projects were associated with longer clinical development thanindependent projects. The largest differences were seen in phases 2 and 3. Collaborations between small firms wereassociated with longer clinical development times than other types of collaboration. This result suggests considerationshould be given, when devising a new drug development strategy, to the fact that collaborative development can slowdown the clinical development process
|
|
|
KEYWORD
|
|
|
Clinical development time, Collaboration, Innovation speed, New drugs
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|